DW13B6Z
Brachytherapy Abdomen to None with Cesium 131 (Cs-131), Low Dose Rate (LDR) Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | D Radiation Therapy |
| Body System | W Anatomical Regions |
| Operation | 1 Brachytherapy |
| Body Part | 3 Abdomen |
| Approach | B Low Dose Rate (LDR) |
| Device | 6 Cesium 131 (Cs-131) |
| Qualifier | Z None |
Procedure Overview
This family covers brachytherapy, the placement of sealed radioactive sources directly into or next to an anatomical region rather than into a single specifically classified organ. Small radioactive seeds, wires, or applicators are positioned so the radiation dose is concentrated close to the treatment area while sparing surrounding tissue more than external beam methods typically allow.
It's used for regional tumors or postoperative tumor beds where placing the source directly at the site gives better dose control, and sometimes for recurrent disease in a region previously treated with external radiation. The sources may be left temporarily or permanently depending on the isotope and clinical goal, and the procedure is performed by a radiation oncologist, often with imaging guidance to confirm correct placement.
Anatomy & Axis Detail
Abdomen
Abdominal brachytherapy involves placing sealed radioactive sources within the abdominal cavity or against its wall, generally to treat tumors of the pancreas, liver, or peritoneal surfaces where surgical resection is incomplete or not feasible. Catheters or applicators are typically positioned intraoperatively at the time of debulking surgery so that a boost dose can be delivered directly to residual disease or a tumor bed before the abdomen is closed, sparing bowel loops and other mobile abdominal contents that would otherwise migrate through an external beam field. Because abdominal organs shift with respiration and peristalsis, source fixation and postoperative timing are important procedural considerations, and the abdomen is coded as the body part when treatment targets this general cavity rather than one specifically named abdominal organ.
Modality Qualifier: Low Dose Rate (LDR)
Low Dose Rate (LDR) denotes brachytherapy using a source of lower activity that remains implanted or applied over an extended period, from many hours to a few days, exploiting continuous low-level irradiation for tumor control. This differs from High Dose Rate (HDR), which compresses the same general goal into brief, higher-intensity sessions, and LDR is often chosen for permanent seed implants such as certain prostate treatments.
Isotope: Cesium 131 (Cs-131)
Cesium-131 is a permanent-seed brachytherapy isotope, similar in application to I-125 and Pd-103, implanted for prostate and other solid tumors, but distinguished by its notably shorter half-life of roughly 9.7 days. This compresses dose delivery into a shorter window than either I-125 or Pd-103, which can be clinically relevant for tumor kinetics and post-implant management.
Coding & Documentation
A code from this family requires documentation naming the anatomical region treated (rather than a specific organ with its own body system) along with the isotope or source type used and whether the implant is temporary or permanent, since these details determine the qualifier. Operative notes describing applicator or seed placement, along with dosimetry records, support the code choice. Coders most often err by coding to Anatomical Regions when the physician's note actually identifies a specific organ that has a dedicated body system, or by missing whether the source was left in place versus removed after treatment, which changes the qualifier selected.
Commonly Confused With
This is frequently confused with Brachytherapy coded to a named body system, such as Gynecological or Urinary, when the treated site is actually a specific organ; the distinguishing factor is whether the note names an organ (use that body system) or describes a regional field or postsurgical bed spanning tissue not tied to one organ (use Anatomical Regions). It also overlaps conceptually with Beam Radiation to the same region, but the presence of an implanted or applied source rather than an external delivery is what separates brachytherapy from beam therapy.